DE60129805D1 - Genetisches testverfahren zur bestimmung des risikos der entwicklung von pouchitis - Google Patents

Genetisches testverfahren zur bestimmung des risikos der entwicklung von pouchitis

Info

Publication number
DE60129805D1
DE60129805D1 DE60129805T DE60129805T DE60129805D1 DE 60129805 D1 DE60129805 D1 DE 60129805D1 DE 60129805 T DE60129805 T DE 60129805T DE 60129805 T DE60129805 T DE 60129805T DE 60129805 D1 DE60129805 D1 DE 60129805D1
Authority
DE
Germany
Prior art keywords
pouchitis
determining
risk
development
allele
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60129805T
Other languages
English (en)
Other versions
DE60129805T2 (de
Inventor
Kent D Taylor
Huiying Yang
Jerome I Rotter
Phillip R Fleshner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cedars Sinai Medical Center
Original Assignee
Cedars Sinai Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedars Sinai Medical Center filed Critical Cedars Sinai Medical Center
Publication of DE60129805D1 publication Critical patent/DE60129805D1/de
Application granted granted Critical
Publication of DE60129805T2 publication Critical patent/DE60129805T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE60129805T 2000-04-12 2001-04-10 Genetisches testverfahren zur bestimmung des risikos der entwicklung von pouchitis Expired - Lifetime DE60129805T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US556868 2000-04-12
US09/556,868 US6348316B1 (en) 2000-04-12 2000-04-12 Genetic testing for determining the risk of pouchitis development
PCT/US2001/011646 WO2001079550A2 (en) 2000-04-12 2001-04-10 Genetic testing for determining the risk of pouchitis development

Publications (2)

Publication Number Publication Date
DE60129805D1 true DE60129805D1 (de) 2007-09-20
DE60129805T2 DE60129805T2 (de) 2007-12-27

Family

ID=24223159

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60129805T Expired - Lifetime DE60129805T2 (de) 2000-04-12 2001-04-10 Genetisches testverfahren zur bestimmung des risikos der entwicklung von pouchitis

Country Status (10)

Country Link
US (1) US6348316B1 (de)
EP (1) EP1274864B1 (de)
JP (2) JP4991031B2 (de)
AT (1) ATE369441T1 (de)
AU (1) AU2001255291A1 (de)
CA (1) CA2406346A1 (de)
DE (1) DE60129805T2 (de)
ES (1) ES2288168T3 (de)
IL (1) IL152203A (de)
WO (1) WO2001079550A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10236711A1 (de) * 2002-08-09 2004-02-26 Universität Hohenheim Polymorphe Mikrosatellitenloci in Genen für die Prädiagnostik
US9072728B2 (en) * 2003-09-18 2015-07-07 Children's Medical Center Corporation Treatment of severe distal colitis
DE602005022924D1 (de) * 2004-12-08 2010-09-23 Cedars Sinai Medical Ct Los An Verfahren zur diagnose von morbus crohn
WO2008101133A2 (en) * 2007-02-14 2008-08-21 Cedars-Sinai Medical Center Methods of using genes and genetic variants to predict or diagnose inflammatory bowel disease
US11268149B2 (en) 2004-12-08 2022-03-08 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease
US10544459B2 (en) 2004-12-08 2020-01-28 Cedars-Sinai Medical Center Methods of using genetic variants for the diagnosis and treatment of inflammatory bowel disease
WO2008106451A2 (en) * 2007-02-26 2008-09-04 Cedars-Sinai Medical Center Methods of using single nucleotide polymorphisms in the tl1a gene to predict or diagnose inflammatory bowel disease
WO2008137762A2 (en) * 2007-05-04 2008-11-13 Cedars-Sinai Medical Center Methods of diagnosis and treatment of crohn's disease
WO2010039931A2 (en) * 2008-10-01 2010-04-08 Cedars-Sinai Medical Center Methods of using il17rd and il23-il17 pathway genes to diagnose crohn's disease
US20100015156A1 (en) * 2007-03-06 2010-01-21 Cedars-Sinai Medical Center Diagnosis of inflammatory bowel disease in children
US8486640B2 (en) * 2007-03-21 2013-07-16 Cedars-Sinai Medical Center Ileal pouch-anal anastomosis (IPAA) factors in the treatment of inflammatory bowel disease
US20100184050A1 (en) * 2007-04-26 2010-07-22 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease in the puerto rican population
US20110189685A1 (en) * 2008-10-22 2011-08-04 Cedars-Sinai Medical Center Methods of using jak3 genetic variants to diagnose and predict crohn's disease
US20110229471A1 (en) * 2008-11-26 2011-09-22 Cedars-Sinai Medical Center Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
WO2010075579A2 (en) 2008-12-24 2010-07-01 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (mr-uc) requiring colectomy
BR112015024752A2 (pt) 2013-03-27 2017-07-18 Cedars Sinai Medical Center mitigação e reversão da fibrose e inflamação através da inibição da função de tl1a e vias de sinalização relacionadas
EP4105236A1 (de) 2013-07-19 2022-12-21 Cedars-Sinai Medical Center Anti-tl1a (tnfsf15) antikörper zur behandlung von entzündlichen darmerkrankungen
KR102464372B1 (ko) 2016-03-17 2022-11-04 세다르스-신나이 메디칼 센터 Rnaset2를 통한 염증성 장 질환의 진단 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL91562A0 (en) 1989-09-07 1990-04-29 Yeda Res & Dev Interferon-gamma receptor fragment and its production
JP3887011B2 (ja) 1992-12-29 2007-02-28 ジェネンテク，インコーポレイテッド ＩＦＮ−γインヒビターによる炎症性腸疾患の処置
JPH09506263A (ja) 1993-12-09 1997-06-24 アゲット，ミヒェル ＩＦＮ−γレセプターβ−鎖およびその誘導体
US6033864A (en) * 1996-04-12 2000-03-07 The Regents Of The University Of California Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
WO1997038642A1 (en) * 1996-04-12 1997-10-23 Cedars-Sinai Medical Center Methods of determining the risk of pouchitis development
PT1818343E (pt) 1998-01-23 2012-07-12 Hoffmann La Roche Anticorpos contra a il-12 humana

Also Published As

Publication number Publication date
IL152203A0 (en) 2003-05-29
JP4991031B2 (ja) 2012-08-01
DE60129805T2 (de) 2007-12-27
EP1274864B1 (de) 2007-08-08
EP1274864A2 (de) 2003-01-15
ATE369441T1 (de) 2007-08-15
AU2001255291A1 (en) 2001-10-30
US6348316B1 (en) 2002-02-19
JP2012115278A (ja) 2012-06-21
ES2288168T3 (es) 2008-01-01
JP2003530842A (ja) 2003-10-21
WO2001079550A2 (en) 2001-10-25
IL152203A (en) 2009-09-01
CA2406346A1 (en) 2001-10-25
WO2001079550A3 (en) 2002-10-10

Similar Documents

Publication Publication Date Title
DE60129805D1 (de) Genetisches testverfahren zur bestimmung des risikos der entwicklung von pouchitis
Reiter et al. A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element
Pyo et al. Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus
Pinceel et al. Extreme mtDNA divergences in a terrestrial slug (Gastropoda, Pulmonata, Arionidae): accelerated evolution, allopatric divergence and secondary contact
GB0325653D0 (en) CST emulsions
BRPI0406470A (pt) Método para a purificação de polipeptìdeo heterólogo e caldo ou homogeneizado de fermentação
DK1546174T3 (da) Fremgangsmåder og sammensætninger til RNA-interferens
IL175319A0 (en) Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof
ATE414162T1 (de) Verfahren und materialien zur herstellung von glucosamin
PT973794E (pt) Receptores de netrina
JP2003530842A5 (de)
CY1110804T1 (el) Γονιδιακη παραλλαγη του γονιδιου αννεξινης α5
AU2002330791A1 (en) Marker assisted selection of bovine for improved milk composition
AU2003902823A0 (en) Biologically active oils
OHTSUKA et al. Significance of phosphorylation/dephosphorylation of 46K protein (s) in regulation of superoxide anion production in intact guinea pig polymorphonuclear leukocytes
DE69533626D1 (de) Tioredioxine h aus zwig und hart-weizen und ähnliche proteine, diese kodierende dna-fragmente und verfahren zu ihrer herstellung
Xia et al. The origin and evolution of chromosomal reciprocal translocation in quasipaa boulengeri (Anura, dicroglossidae)
AU2904197A (en) Diagnostic method and apparatus based on polymorphism in an IL-6 gene
Roudknar et al. Detection of Rare and Unknown Mutations in ß-tathalassemia Traits in Iran
Hidaka et al. Genetic analysis of a Japanese patient with butyrylcholinesterase deficiency
ATE419393T1 (de) Polymorphismus des igf2-gens und verbesserte produktionseigenschaften von rindern
MY132876A (en) Method for visually demonstrating the effectiveness of an anti-bacteria attachment composition
WO2002086067A3 (en) Mycobacterial sulfation pathway proteins and methods of use thereof
WO2004016738A3 (en) Method and composition for treating and preventing hepatitis c infection
WO2005056830A8 (en) Genetic reference materials

Legal Events

Date Code Title Description
8364 No opposition during term of opposition